Cellular mechanisms of T cell mediated drug hypersensitivity

Current Opinion in Immunology

Volumn 16, Issue 6, 2004, Pages 732-737

  Gerber, Basil O ^a   Pichler, Werner J ^a  

^a Inselspital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CONTRAST MEDIUM; HAPTEN; LAMOTRIGINE; LIDOCAINE; MEPIVACAINE; PHENYLENEDIAMINE; SULFAMETHOXAZOLE; T LYMPHOCYTE RECEPTOR;

ALLELE; ANTIGEN PRESENTING CELL; CELL CLONE; CELL FUNCTION; CELL STIMULATION; CELL SURFACE; DRUG ACTIVITY; DRUG HYPERSENSITIVITY; DRUG POTENCY; DRUG SPECIFICITY; ENZYME SPECIFICITY; GENETIC TRANSFECTION; HUMAN; HYBRID CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; REVIEW; T LYMPHOCYTE;

ANIMALS; DRUG HYPERSENSITIVITY; HAPTENS; HUMANS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSFECTION;

EID: 7044226467     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2004.09.016     Document Type: Review

References (42)

1. W.J. Pichler Delayed drug hypersensitivity reactions Ann Intern Med 139 2003 683 693 A comprehensive review on how drugs interact with the immune system, leading to different forms of immune reactions. Based on the heterogeneous picture of drug-induced exanthema, a new subclassification of type IV reactions into IVa-IVd is proposed.
2. J.C. Roujeau, and R.S. Stern Severe adverse cutaneous reactions to drugs N Engl J Med 331 1994 1272 1285
3. Y. Hari, K. Frutig-Schnyder, M. Hurni, N. Yawalkar, M.P. Zanni, B. Schnyder, A. Kappeler, S. von Greyerz, L.R. Braathen, and W.J. Pichler T cell involvement in cutaneous drug eruptions Clin Exp Allergy 31 2001 1398 1408
4. B.K. Park, M. Pirmohamed, and N.R. Kitteringham Role of drug disposition in drug hypersensitivity: A chemical, molecular, and clinical perspective Chem Res Toxicol 11 1998 969 987
5. D.J. Naisbitt, S.F. Gordon, M. Pirmohamed, and B.K. Park Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment Drug Saf 23 2000 483 507
6. M. Manfredi, M. Severino, S. Testi, D. Macchia, G. Ermini, W.J. Pichler, and P. Campi Detection of specific IgE to quinolones J Allergy Clin Immunol 113 2004 155 160
7. N. Yawalkar, Y. Hari, K. Frutig, F. Egli, T. Wendland, L.R. Braathen, and W.J. Pichler T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic J Invest Dermatol 115 2000 647 652
8. D.J. Naisbitt, M. Britschgi, G. Wong, J. Farrell, J.P. Depta, D.W. Chadwick, W.J. Pichler, M. Pirmohamed, and B.K. Park Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones Mol Pharmacol 63 2003 732 741 A detailed analysis of the specific T cell immune response in patients with carbamazepine hypersensitivity. The clones analyzed in detail secreted high amounts of IFN-γ but low amounts of IL-5, which distinguishes them from clones isolated from patients with cutaneous symptoms. Interestingly, all clones expressed the skin-homing receptor cutaneous lymphocyte antigen (CLA) and secreted substantial amounts of IFN-γ. Moreover, the parent compound was recognized by the TCCs.
9. D.J. Naisbitt, J. Farrell, G. Wong, J.P. Depta, C.C. Dodd, J.E. Hopkins, C.A. Gibney, D.W. Chadwick, W.J. Pichler, M. Pirmohamed, and B.K. Park Characterization of drug-specific T cells in lamotrigine hypersensitivity J Allergy Clin Immunol 111 2003 1393 1403 A detailed analysis of the specific T cell immune response in patients with systemic lamotrigine hypersensitivity with hepatic involvement. Interestingly, all clones expressed the skin-homing receptor cutaneous lymphocyte antigen (CLA) and secreted substantial amounts of IFN-γ, IL-5 and several chemokines. Moreover, the parent compound was recognized by the TCCs.
10. E. Padovan, T. Bauer, M.M. Tongio, H. Kalbacher, and H.U. Weltzien Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy Eur J Immunol 27 1997 1303 1307
11. A. Cavani, D. Mei, E. Guerra, S. Corinti, M. Giani, L. Pirrotta, P. Puddu, and G. Girolomoni Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells J Invest Dermatol 111 1998 621 628
12. K. Gamerdinger, C. Moulon, D.R. Karp, J. Van Bergen, F. Koning, D. Wild, U. Pflugfelder, and H.U. Weltzien A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel J Exp Med 197 2003 1345 1353 This is a very detailed and comprehensive structure/function analysis of a Ni-specific TCC, which identifies three Ni coordination sites, two on the TCR and one in the MHC. The direct linkage between TCR and MHC is similar to superantigen stimulation even though idiotypic residues are required for stimulation.
13. 2+, a specific peptide, the DR52c allele, and a histidine at position 81 of the MHC β chain.
14. P. Griem, M. Wulferink, B. Sachs, J.B. Gonzalez, and E. Gleichmann Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 19 1998 133 141
15. S.R. Knowles, J. Uetrecht, and N.H. Shear Idiosyncratic drug reactions: the reactive metabolite syndromes Lancet 356 2000 1587 1591
16. W.J. Pichler Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept Curr Opin Allergy Clin Immunol 2 2002 301 305
17. B. Schnyder, D. Mauri-Hellweg, M. Zanni, F. Bettens, and W.J. Pichler Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones J Clin Invest 100 1997 136 141
18. M.P. Zanni, S. von Greyerz, Y. Hari, B. Schnyder, and W.J. Pichler Recognition of local anesthetics by alphabeta+ T cells J Invest Dermatol 112 1999 197 204
19. M.P. Zanni, D. Mauri-Hellweg, C. Brander, T. Wendland, B. Schnyder, E. Frei, S. von Greyerz, A. Bircher, and W.J. Pichler Characterization of lidocaine-specific T cells J Immunol 158 1997 1139 1148
20. S. Sieben, Y. Kawakubo, T. Al Masaoudi, H.F. Merk, and B. Blomeke Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones J Allergy Clin Immunol 109 2002 1005 1011
21. C. Christiansen, W.J. Pichler, and T. Skotland Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations Eur Radiol 10 2000 1965 1975
22. A.E. Cribb, and S.P. Spielberg Sulfamethoxazole is metabolized to the hydroxylamine in humans Clin Pharmacol Ther 51 1992 522 526
23. D. Mauri-Hellweg, M. Zanni, E. Frei, F. Bettens, C. Brander, D. Mauri, E. Padovan, H.U. Weltzien, and W.J. Pichler Cross-reactivity of T cell lines and clones to beta-lactam antibiotics J Immunol 157 1996 1071 1109
24. M.P. Zanni, S. von Greyerz, B. Schnyder, K.A. Brander, K. Frutig, Y. Hari, S. Valitutti, and W.J. Pichler HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes J Clin Invest 102 1998 1591 1598
25. A. Nassif, A. Bensussan, G. Dorothee, F. Mami-Chouaib, N. Bachot, M. Bagot, L. Boumsell, and J.C. Roujeau Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis J Invest Dermatol 118 2002 728 733
26. B. Schnyder, C. Burkhart, K. Schnyder-Frutig, S. von Greyerz, D.J. Naisbitt, M. Pirmohamed, B.K. Park, and W.J. Pichler Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals J Immunol 164 2000 6647 6654
27. J. Vollmer, H.U. Weltzien, A. Dormoy, F. Pistoor, and C. Moulon Functional expression and analysis of a human HLA-DQ restricted, nickel-reactive T cell receptor in mouse hybridoma cells J Invest Dermatol 113 1999 175 181
28. J.P. Depta, F. Altznauer, K. Gamerdinger, C. Burkhart, H.U. Weltzien, and W.J. Pichler Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity J Allergy Clin Immunol 113 2004 519 527 This is a comprehensive analysis of hybridoma cells transfected with SMX-specific TCR to investigate the influence of receptor density, specificity and cross-specificity on various cellular responses. A higher density led to a broader cross-reactivity, closely mimicking the phenotype of the original TCCs.
29. C. Burkhart, S. von Greyerz, J.P. Depta, D.J. Naisbitt, M. Britschgi, K.B. Park, and W.J. Pichler Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole- metabolite-specific human CD4+ T-cells Br J Pharmacol 132 2001 623 630
30. M.P. Zanni, S. von Greyerz, B. Schnyder, T. Wendland, and W.J. Pichler Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific αβ+ T cell clones Int Immunol 10 1998 507 515
31. C. Burkhart, M. Britschgi, I. Strasser, J.P. Depta, S. von Greyerz, V. Barnaba, and W.J. Pichler Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides Clin Exp Allergy 32 2002 1635 1643
32. S. von Greyerz, M.P. Zanni, K. Frutig, B. Schnyder, C. Burkhart, and W.J. Pichler Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human αβ+ T cell clones J Immunol 162 1999 595 602
33. S. von Greyerz, G. Bultemann, K. Schnyder, C. Burkhart, B. Lotti, Y. Hari, and W.J. Pichler Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones Int Immunol 13 2001 877 885
34. M. Pirmohamed, and B.K. Park Genetic susceptibility to adverse drug reactions Trends Pharmacol Sci 22 2001 298 305
35. M. Pirmohamed, and B.K. Park Cytochrome P450 enzyme polymorphisms and adverse drug reactions Toxicology 192 2003 23 32
36. A. Alfirevic, A.C. Stalford, F.J. Vilar, E.G. Wilkins, B.K. Park, and M. Pirmohamed Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity Br J Clin Pharmacol 55 2003 158 165
37. M. Pirmohamed, K. Lin, D. Chadwick, and B.K. Park TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients Neurology 56 2001 890 896
38. S. Mallal, D. Nolan, C. Witt, G. Masel, A.M. Martin, C. Moore, D. Sayer, A. Castley, C. Mamotte, D. Maxwell, I. James, and F.T. Christiansen Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir Lancet 359 2002 727 732
39. W.H. Chung, S.I. Hung, H.S. Hong, M.S. Hsih, L.C. Yang, H.C. Ho, J.Y. Wu, and Y.T. Chen Medical genetics: a marker for Stevens-Johnson syndrome Nature 428 2004 486 This is the second demonstration of an HLA association with a drug hypersensitivity reaction, and the strongest known association between an HLA allele and any disease to date.
40. O.B. Engler, I. Strasser, D.J. Naisbitt, A. Cerny, and W.J. Pichler A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals Toxicology 197 2004 47 56 This paper describes for the first time the induction of a primary T cell immune response against a chemically inert drug in healthy individuals who have not been exposed to the drug previously.
41. N.R. Beeley Can peptides be mimicked? Drug Discov Today 5 2000 354 363
42. N. Snowden, D.M. Dietch, L.S. Teh, R.C. Hilton, and M.R. Haeney Antibody deficiency associated with gold treatment: natural history and management in 22 patients Ann Rheum Dis 55 1996 616 621